Ashok Leyland in discussions to raise funds for e-mobility service arm Ohm along with EV subsidiary SwitchWhile the company was non-committal on the quantum of fund raise for Ohm, ET learns the company may be looking at raising anywhere between ...
14 Feb, 2022, 07.58 PM IST
Ashok Leyland to transfer EV business to step-down armAlso, the board at its meeting held on Friday has approved the transfer of its eMaaS (e-mobility as a service) business for Rs 65 crore to ...
12 Nov, 2021, 11.08 PM IST
Ashok Leyland to carve out two new units to strengthen green transport solutionsThe first unit -- Switch Mobility Automotive Ltd -- is being formed to carry on the electric vehicle strategy in India and forms part of it...
07 Apr, 2021, 11.57 PM IST
DSP small cap fund sells 3% in Eveready IndustriesAll three funds bought the stakes at Rs 200 per share.
07 Mar, 2019, 08.11 AM IST
Demonetisation hits gambling company investorsAs per September filing Jhunjhunwala together with his wife owns 9.74% stake in the company while OHM had 1.38% and Quest Portfolio 1.08% s...
15 Nov, 2016, 03.56 PM IST
Ranbaxy gets FDA nod to sell generic Diovan tablets in USRanbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell generic Valsartan tablets.
27 Jun, 2014, 12.58 PM IST
Ranbaxy Laboratories recalls 29,790 packs of anti-allergy drug in USRanbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to de...
02 May, 2014, 08.08 PM IST
Ranbaxy to suffer operating losses post USFDA ban: Surajit Pal, Prabhudas Lilladher"For the Ohm Labs to manufacture formulations, around 70% of the supplies came from the Toansa API plant. So that business would be impacte...
24 Jan, 2014, 02.48 PM IST
Past issues, heavy attrition at the root of Ranbaxy’s problems: Ranjit Kapadia, Centrum Broking"We have a 'sell' rating with a target price of Rs 360. Now we have to watch the situation today as it unfolds and accordingly, we will tak...
24 Jan, 2014, 01.12 PM IST
Ranbaxy's US unit gets USFDA's establishment inspection reportThe US health regulator has given Ranbaxy Laboratories' American arm Ohm Laboratories Inc a report indicating closure of inspection of its ...
12 Oct, 2013, 07.50 AM IST
Ranbaxy rallies 19%: Just another flash in the pan, say analystsHowever, analysts are not expecting the stock to continue with its uptrend as USFDA overhang remains.
11 Oct, 2013, 01.38 PM IST
Ranbaxy's hunt for FDA-okayed plants in India pushes stock higherRanbaxy is looking at FDI-okayed plants in an attempt to reduce risks arising out of issues with its Mohali plant, said two persons familia...
07 Oct, 2013, 09.59 AM IST
Ranbaxy hunts for FDA-okayed plants in IndiaThis move will ensure launch plans are not jeopardised following Mohali setback.
07 Oct, 2013, 05.40 AM IST
- Foreign companies to pay tax at 4.22% on all revenue from seismic data contracts
In a ruling, the Authority of Advanced Rulings held that foreign firms would not enjoy any leeway even if their income falls under the labe...
17 May, 2011, 04.01 PM IST
- Unhappy FDA tells Ranbaxy to review units
The US drugs regulator has asked Indian pharma company Ranbaxy to immediately assess the manufacturing practices at its plants that make dr...
05 Feb, 2010, 02.45 AM IST
- Ranbaxy Laboratories may start operations in new plants this year
The country's largest drug company by sales, is also expanding the US plant to mitigate the US drug regulator’s embargo on drugs made at tw...
14 May, 2009, 09.06 PM IST
- Ranbaxy up 3% on USFDA nod for migraine drug
Amid the general weakness in the market, shares of Ranbaxy Laboratories bucked the trend after it received the US Food and Drug Administrat...
11 Feb, 2009, 10.36 AM IST